Navigation Links
Blood-Thinner Plavix Works Harder in Smokers
Date:8/4/2008

But the finding certainly isn't any reason to start or continue smoking, researchers say

MONDAY, Aug. 4 (HealthDay News) -- The widely used anti-clotting drug Plavix appears to have a stronger effect in people who smoke, a study indicates.

Plavix (clopidogrel) is often given to heart attack patients after the attack. It inhibits formation of clots by blood cells called platelets.

The study of 259 people given Plavix because of coronary conditions found that those who smoked had significantly less clot formation than nonsmokers.

But it's still too early to say that doctors should include smoking among the factors that affect whether Plavix should be prescribed or how large the dose should be, said study lead author Dr. Paul A. Gurbel, associate professor of medicine at Johns Hopkins University and director of the Sinai Center for Thrombosis Research, Baltimore.

"I don't know if we can jump to that conclusion yet," Gurbel said. "We need to study this further. We do know from two large-scale clinical trials that smokers benefited more when they got Plavix therapy. Maybe smoking does something to make Plavix work better."

That "something" probably occurs in the liver, where the drug is metabolized, Gurbel said. Cigarette smoking increases the production of CYP1A2, a liver enzyme that converts the drug to its active form, he said.

"Current smoking was an independent predictor of low platelet aggregation," the journal report said.

Of course, lower clotting action can sometimes mean a higher risk for bleeding. But Gurbel said that, based on these early findings, "we don't know if [smoking patients] will bleed more."

The findings were expected to be published in the Aug. 12 issue of the Journal of the American College of Cardiology.

Plavix is widely used to prevent coronary problems and is commonly prescribed after a heart attack. A standard recommendation for heart attack patients includes a year of combined therapy with Plavix and aspirin, another clot-preventing drug.

The indication that smoking reduces platelet stickiness in people given Plavix "is certainly observational at this point" and requires proof in a large, controlled trial, Gurbel said.

"Were trying to get funding for a trial right now," he said.

The trial he envisions would enroll a large group of smokers who would all be prescribed Plavix. "Then we would remove the smoking in half the group," Gurbel said. "We would see whether that removal adds support for our observation."

The hardest part of such a trial would be to get half a group of smokers to quit, Gurbel acknowledged.

"And were definitely not telling people to smoke if they have heart disease," he said. Smoking is high on the list of risk factors for heart attack, stroke and other cardiovascular problems, Gurbel noted.

The study was funded in part by a grant from drug maker Daiichi Sankyo Inc.

More information

For move on Plavix, head to the U.S. National Library of Medicine.



SOURCES: Paul A. Gurbel, M.D., director, Sinai Center for Thrombosis Research, Baltimore; Aug. 12, 2008, Journal of the American College of Cardiology


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Blood-Thinner No Help for Dialysis Treatment
2. Blood-Thinner Contaminant Traced to Chinese Plant
3. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
4. First 90 Days After Stopping Plavix Most Dangerous
5. Once-Daily Combo Works for New HIV Patients
6. Plexus Consulting Group Works With a USAID-Funded Project to Help the Private Hospitals Association of Jordan Create a Roadmap for the Future
7. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
8. DIA And FDA To Host Two Important Critical Path Workshops
9. Autisms social struggles due to disrupted communication networks in brain
10. Ceridian LifeWorks Offers CareGiverHelper Service to Clients to Ease Stress of Family Caregiving
11. Workshop Helps Parents, Kids Talk About Sex
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood-Thinner Plavix Works Harder in Smokers
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology: